Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.95
GeoVax Labs, Inc. issued 402,000 shares of common stock of common stock to institutional investors for public offering price of $2.31 per share, net proceeds approximately $865,000.
- Security
- common stock
- Shares
- 402,000 shares of common stock
- Purchaser
- institutional investors
- Consideration
- public offering price of $2.31 per share, net proceeds approximately $865,000
Exact text from the filing
purchase an aggregate of 432,902 shares of Common Stock (such shares issuable upon exercise of the Common Warrants, the “Common Warrant Shares”). The public offering price was $2.31 for each Share and $2.30999 per Pre-Funded Warrant. The Pre-Funded Warrants have an exercise price of $0.00001 per share, are exercisable immediately and may be exercised at any
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
GeoVax Labs, Inc. entered into Purchase Agreement with the purchasers party thereto valued at approximately $865,000 (effective 2026-02-13).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- the purchasers party thereto
- Value
- approximately $865,000
- Effective
- 2026-02-13
Exact text from the filing
On February 13, 2026, GeoVax Labs, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with the purchasers party thereto, pursuant to which the Company agreed to issue and sell, in a registered direct offering (the “Offering”), an aggregate of (i) 402,000 shares (the “Shares”) of the Company’s common stock, $0.001 par value per share (the “Common Stock”) and (ii) pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to an aggregate of 30,902 shares of Common Stock (the “Pre-Funded Warrant Shares”).
View on SEC.gov